Please login to the form below
Synergy
This page shows the latest Synergy news and features for those working in and with pharma, biotech and healthcare.
Astellas and PeptiDream announce protein degrader research collaboration
We hope this collaboration will bring synergies between the two companies' cutting-edge research and will ultimately lead to the expansion of Astellas’ portfolio and development of new therapeutics for patients
Latest news
-
Astellas signs $962m rare eye disease deal with 4D Molecular Therapeutics
Adam Pearson, chief strategy officer at Astellas, said: "We believe that this collaboration will bring synergies between the two companies' cutting-edge research, and will ultimately lead to the development of
-
Astellas and Cullgen announce protein degrader partnership worth up to $1.9bn
We hope this collaboration will bring synergies between the two companies' cutting-edge research, and will ultimately lead to the expansion of Astellas’ portfolio and development of new therapeutics for patients
-
EIT Health and IHI join forces to support health research and innovation across Europe
This MoU underscores our joint commitment to working together, so that we can benefit from each other’s strengths and exploit synergies wherever possible.
-
Sartorius signs agreement to acquire Polyplus for €2.4bn
our offering of cell culture media and critical components for the development and manufacture of advanced therapies, and there are also strong synergies with our portfolio of downstream solutions for the
-
Kite and Arcellx partner to develop and commercialise multiple myeloma candidate
The synergies between the two companies are a natural fit.”. Once the deal is finalised, Arcellx will be set to receive an upfront cash payment of $225m and $100m equity investment,
More from news
Approximately 11 fully matching, plus 163 partially matching documents found.
Latest Intelligence
-
The impact of AI on digital health: the fifth industrial revolution
By Matt Lewis. We’re about to enter the Fifth Industrial Revolution where artificial intelligence (AI) and humans acting in synergy create an outsized impact on the world.
-
Strategic behaviour
Then, the same interaction between company culture and individual attributes changed the direction of the synergy, leading to much better organisational citizenship behaviours and, consequently, more effective strategising.
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
Transparency and the dynamic injection of human decision-making into AI models not only supports real-world validation and accountability, it generates a key synergy between AI and HI (human insight).
-
How should healthcare harness creativity?
better. Have the bravery to trust in those who capturing hearts and minds, those who are pioneering new ways of communication, because when you find the perfect alchemy of audience synergy,
-
The science of the deal
The most successful contracts are those that are structured to both mitigate risk and ensure that the synergies between the partners are fully exploited.
More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.
Latest appointments
-
Bedrock announces a number of new hires
Previously, Wasek has held a number of roles within the healthcare communications sector, at agencies including Lucid Group and Synergy Vision. ... Most recently, she worked as a principal medical writer at Lucid Group, and as creative engagement lead at
-
New executive appointments at Synergy Vision
Gallagher has worked at Synergy Vision since its inception, having been part of the founding team. ... During her time at Synergy, Gallagher (pictured left) has worked as both a director and managing director.
-
M Booth Health appoints Karen Strauss to lead strategy and innovation
Strauss is also tasked with finding synergies between M Booth Health and M Booth – although it operates as its own individual company, M Booth Health reports to M Booth CEO Dale
-
New faces at Synergy Vision, Makara Health and JPA Health
The latest movers in healthcare comms. Synergy Vision . Synergy Vision has appointed Paula Hensler (pictured below, left) as its new director of scientific strategy, who brings more than 18 years of ... Commenting on her appointment, Hensler said:
-
Synergy Studio continues to grow
Mohamed Alani joins team in Richmond. Healthcare communs agency Synergy welcomes a new graphic designer to its growing studio. ... Synergy Studio complements Synergy’s scientific offering by contributing creative and smart solutions to clients.
More from appointments
Approximately 3 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Onyx Health Welcomes Sarah Seilly as Head of Medical Education
Leveraging Onyx Health’s deep-rooted expertise in omnichannel for healthcare communications, Sarah’s appointment will enable Onyx Health to introduce a new dimension of synergy between educational content delivery and
-
THE EVOLVING ROLE OF PROCUREMENT?
Collaboration with suppliers has always been important. With the changing landscape, procurement cannot afford to communicate with suppliers just over price - instead, there’s a focus on improving synergies with them.
-
Healthcare services entrepreneur David Rowley joins KVA
The synergy of values with David’s people first approach aligns perfectly to fuel KVA’s global expansion.
-
Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)
He said: “When the FH and PAI leadership teams met for the first time, the synergies and fit were immediately apparent.
-
Paul Archer promoted to Chief Commercial Strategy Officer, Envision Pharma Group
In his new role, Archer will lead the development of an integrated commercial group strategy to drive continued revenue growth through service synergies and the implementation of new services. ... Commercial Strategy Officer as we continue to exploit
More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.
Subscribe to our email news alerts
- Actinic keratosis – a common skin condition that can lead to skin cancer
- The paper trail
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
No results were found
PMHub
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
